Post-Activity Test and Activity Evaluation POST TEST Question Title * 1. According to the Centers for Disease Control and Prevention 2019 list of priority pathogens, which of the following Gram-negative pathogens is not included as an urgent or serious threat? Carbapenem-resistant Enterobacteriaceae (Enterobacterales) MDR Pseudomonas aeruginosa Carbapenem-resistant Stenotrophomonas maltophilia ESBL-producing Enterobacteriaceae (Enterobacterales) Question Title * 2. Ceftolozane-tazobactam exhibits the greatest in vitro activity against which of the following pathogens? KPC-producing Klebsiella pneumoniae MDR Pseudomonas aeruginosa Carbapenem-resistant Acinetobacter baumannii NDM-producing Escherichia coli Question Title * 3. Which of the following newer antimicrobials exhibits the greatest in vitro activity against Acinetobacter baumannii? Ceftazidime-avibactam Ceftolozane-tazobactam Imipenem-relebactam Cefiderocol Question Title * 4. Ceftazidime-avibactam exhibits in vitro activity against Enterobacterales that produce all of the following beta-lactamases except: KPC OXA-48 NDM AmpC Question Title * 5. For a patient without impaired or augmented renal function, which of the following antimicrobial agents requires intravenous dosing every 6 hours? Ceftazidime-avibactam Ceftolozane-tazobactam Imipenem-relebactam Cefiderocol Next